M Holdings Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.66M | Buy |
23,422
+887
| +4% | +$191K | 0.77% | 23 |
|
|
2026
Q1 | $4.73M | Sell |
22,535
-236
| -1% | -$52.4K | 0.32% | 57 |
|
|
2025
Q4 | $5.2M | Buy |
+22,771
| New | +$5.19M | 0.37% | 51 |
|
|
2025
Q3 | – | Sell |
-16,979
| Closed | -$3.12M | – | 88 |
|
|
2025
Q2 | $3.12M | Buy |
16,979
+6,910
| +69% | +$1.28M | 0.54% | 43 |
|
|
2025
Q1 | $2.11M | Buy |
+10,069
| New | +$1.96M | 0.35% | 59 |
|
|
2024
Q3 | – | Sell |
-19,469
| Closed | -$3.33M | – | 93 |
|
|
2024
Q2 | $3.33M | Buy |
+19,469
| New | +$3.23M | 0.43% | 43 |
|
|
2024
Q1 | – | Sell |
-15,391
| Closed | -$2.38M | – | 129 |
|
|
2023
Q4 | $2.38M | Sell |
15,391
-354
| -2% | -$51.6K | 0.27% | 68 |
|
|
2023
Q3 | $2.35M | Buy |
+15,745
| New | +$2.31M | 0.31% | 61 |
|
|
2023
Q1 | – | Sell |
-20,207
| Closed | -$3.09M | – | 469 |
|
|
2022
Q4 | $3.27M | Buy |
20,207
+111
| +0.6% | +$17K | 0.34% | 60 |
|
|
2022
Q3 | $2.7M | Buy |
20,096
+147
| +0.7% | +$21.1K | 0.3% | 74 |
|
|
2022
Q2 | $3.06M | Buy |
19,949
+206
| +1% | +$31.5K | 0.31% | 73 |
|
|
2022
Q1 | $3.2M | Buy |
+19,743
| New | +$2.87M | 0.24% | 79 |
|
|
2021
Q2 | $1.93M | Sell |
17,163
-461
| -3% | -$51.9K | 0.19% | 107 |
|
|
2021
Q1 | $1.91M | Buy |
17,624
+182
| +1% | +$19.5K | 0.17% | 121 |
|
|
2020
Q4 | $1.87M | Buy |
17,442
+901
| +5% | +$86.6K | 0.24% | 93 |
|
|
2020
Q3 | $1.45M | Buy |
16,541
+1,193
| +8% | +$112K | 0.23% | 92 |
|
|
2020
Q2 | $1.51M | Sell |
15,348
-13,722
| -47% | -$1.21M | 0.27% | 87 |
|
|
2020
Q1 | $2.21M | Buy |
29,070
+12,871
| +79% | +$1.1M | 0.33% | 85 |
|
|
2019
Q4 | $1.43M | Sell |
16,199
-806
| -5% | -$66.9K | 0.42% | 67 |
|
|
2019
Q3 | $1.29M | Buy |
17,005
+1,358
| +9% | +$93.1K | 0.4% | 74 |
|
|
2019
Q2 | $1.14M | Sell |
15,647
-26,384
| -63% | -$2.07M | 0.39% | 74 |
|
|
2019
Q1 | $3.39M | Buy |
42,031
+31,332
| +293% | +$2.56M | 0.78% | 28 |
|
|
2018
Q4 | $986K | Sell |
10,699
-156
| -1% | -$13.7K | 0.31% | 86 |
|
|
2018
Q3 | $1.03M | Buy |
10,855
+75
| +0.7% | +$7.11K | 0.27% | 99 |
|
|
2018
Q2 | $999K | Sell |
10,780
-151
| -1% | -$14.7K | 0.27% | 100 |
|
|
2018
Q1 | $1.03M | Sell |
10,931
-325
| -3% | -$35.7K | 0.32% | 93 |
|
|
2017
Q4 | $1.09M | Buy |
11,256
+6
| +0.1% | +$565 | 0.33% | 87 |
|
|
2017
Q3 | $1M | Buy |
11,250
+240
| +2% | +$18.3K | 0.32% | 88 |
|
|
2017
Q2 | $798K | Buy |
11,010
+3,745
| +52% | +$252K | 0.27% | 102 |
|
|
2017
Q1 | $473K | Sell |
7,265
-3,376
| -32% | -$212K | 0.18% | 146 |
|
|
2016
Q4 | $666K | Buy |
10,641
+995
| +10% | +$60.7K | 0.23% | 101 |
|
|
2016
Q3 | $608K | Sell |
9,646
-2,878
| -23% | -$186K | 0.28% | 107 |
|
|
2016
Q2 | $775K | Buy |
12,524
+2,939
| +31% | +$179K | 0.4% | 69 |
|
|
2016
Q1 | $547K | Sell |
9,585
-786
| -8% | -$43.8K | 0.33% | 91 |
|
|
2015
Q4 | $614K | Sell |
10,371
-340
| -3% | -$19.6K | 0.41% | 69 |
|
|
2015
Q3 | $583K | Sell |
10,711
-966
| -8% | -$62.9K | 0.41% | 69 |
|
|
2015
Q2 | $785K | Buy |
11,677
+230
| +2% | +$15K | 0.52% | 53 |
|
|
2015
Q1 | $670K | Buy |
11,447
+4,500
| +65% | +$272K | 0.44% | 66 |
|
|
2014
Q4 | $455K | Sell |
6,947
-135
| -2% | -$8.51K | 0.3% | 102 |
|
|
2014
Q3 | $409K | Buy |
7,082
+150
| +2% | +$8.33K | 0.23% | 107 |
|
|
2014
Q2 | $391K | Buy |
+6,932
| New | +$364K | 0.25% | 108 |
|
|
2014
Q1 | – | Sell |
-6,332
| Closed | -$334K | – | 151 |
|
|
2013
Q4 | $334K | Buy |
+6,332
| New | +$311K | 0.24% | 106 |
|
Other funds holding ABBV
M Holdings Securities's ABBV Position: Q2 2026 in Review
M Holdings Securities increased its AbbVie (ABBV) stake by 3.9% in Q2 2026, buying an estimated $191K and bringing the position to 23,422 shares worth $5.66M. The position accounts for 0.77% of the portfolio, ranked #23.
M Holdings Securities first reported a position in ABBV in Q4 2013 and has held it in 42 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- M Holdings Securities held 23,422 shares of AbbVie worth $5.66M as of Q2 2026.
- M Holdings Securities bought 887 AbbVie shares in Q2 2026, an estimated $191K.
- AbbVie made up 0.77% of M Holdings Securities's portfolio in Q2 2026, its #23 holding.
- M Holdings Securities first reported a position in AbbVie in Q4 2013 and has held it in 42 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on M Holdings Securities's 13F filing for Q2 2026, filed 11 Aug 2026.